Q3 2025 Holdings
Filed 2025-11-14 | 169 holdings | $990.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp del(UTHR)Put | COM | 91307C102 | $88.0M | 209,800 | 8.9% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $75.2M | 750,000 | 7.6% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $53.0M | 175,000 | 5.4% |
| Bristol-Myers Squibb Co(BMY)Put | COM | 110122108 | $36.1M | 800,000 | 3.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $33.4M | 396,098 | 3.4% |
| Uniqure NVCall | CALL | N90064901 | $31.3M | 535,600 | 3.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $27.2M | 415,163 | 2.7% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $26.6M | 277,704 | 2.7% |
| Scholar Rock Hldg Corp(SRRK)Call | COM | 80706P103 | $20.9M | 561,600 | 2.1% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $19.2M | 740,825 | 1.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $17.2M | 280,551 | 1.7% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $15.9M | 615,000 | 1.6% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $14.4M | 100,000 | 1.5% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $14.4M | 100,000 | 1.5% |
| Harrow Inc(HROW)Call | COM | 415858109 | $14.0M | 289,700 | 1.4% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $13.6M | 346,001 | 1.4% |
| PTC Therapeutics Inc(PTCT)Call | COM | 69366J200 | $13.1M | 213,000 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.2M | 222,674 | 1.2% |
| Biohaven LTD(BHVN)Call | CALL | G1110E907 | $12.0M | 796,400 | 1.2% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $11.9M | 176,100 | 1.2% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $11.9M | 1,289,225 | 1.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $11.2M | 311,682 | 1.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $10.8M | 3,372,616 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX)Call | COM | 22663K107 | $10.7M | 257,700 | 1.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $10.3M | 77,800 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.2M | 451,902 | 1.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $10.0M | 249,473 | 1.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $9.8M | 206,854 | 1.0% |
| Jazz Pharmaceuticals PLC(JAZZ)Call | CALL | G50871905 | $9.3M | 70,700 | 0.9% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $9.2M | 2,132,322 | 0.9% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $8.3M | 150,000 | 0.8% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $8.1M | 358,000 | 0.8% |
| Centessa Pharmaceuticals PLC(CNTA)Call | SPONSORED ADS | 152309100 | $7.5M | 307,700 | 0.8% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $7.4M | 967,600 | 0.7% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $6.8M | 413,841 | 0.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $6.3M | 174,959 | 0.6% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $6.2M | 946,259 | 0.6% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $6.1M | 110,900 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $6.0M | 150,000 | 0.6% |
| ARS Pharmaceuticals Inc(SPRY)Call | COM | 82835W108 | $5.7M | 562,400 | 0.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.5M | 130,902 | 0.6% |
| Praxis Precision Medicines I(PRAX)Call | COM NEW | 74006W207 | $5.3M | 100,000 | 0.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $5.3M | 245,518 | 0.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $5.2M | 210,165 | 0.5% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.1M | 333,733 | 0.5% |
| Travere Therapeutics Inc(TVTX)Call | COM | 89422G107 | $5.1M | 214,500 | 0.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $5.1M | 126,979 | 0.5% |
| Anaptysbio Inc(ANAB)Call | COM | 032724106 | $4.9M | 161,100 | 0.5% |
| Anaptysbio Inc(ANAB)Put | COM | 032724106 | $4.9M | 161,100 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV)Call | COM | 483497103 | $4.9M | 400,000 | 0.5% |